Published in

American Association for the Advancement of Science, Science Translational Medicine, 614(13), 2021

DOI: 10.1126/scitranslmed.abg0809

Links

Tools

Export citation

Search in Google Scholar

Alpelisib administration reduced lymphatic malformations in a mouse model and in patients

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Alplesib exerts therapeutic effects in a mouse model of lymphatic anomalies and in six patients with lymphatic malformations over 6 months’ treatment.